Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Aug 2026, 02:17
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
MEDICAMEQ's 49.34% gross margin accelerated to, up from 8.72%.
The company's .72% marginal operating leverage also accelerated to, up from 4.8%. Additionally, MEDICAMEQ's .2% revenue growth year-over-year accelerated to, up from 44.7%. The stock's .75 INR close price accelerated to, up from 228.73 INR. Furthermore, MEDICAMEQ's .
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 49.34 % | 8.72 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 8.72 % | 4.8 | ▲ |
| REVENUE_GROWTH_YOY | 80.2 % | 44.7 | ▲ |
| PRICE_CHANGE_PERCENT | 6.567 % | — | - |
| DAILY_VOLUME | 49,191 shares | 28,036 | ▲ |
| CLOSE_PRICE | 243.75 INR | 228.73 | ▲ |